Bosutinib (BOS) versus Imatinib (IMA) for newly diagnosed Chronic Phase (CP) Chronic Myeloid Leukemia (CML): Final 5-year results from the BFORE trial
ONCOLOGY RESEARCH AND TREATMENT(2021)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ONCOLOGY RESEARCH AND TREATMENT(2021)